Dear distinguished guests and esteemed participants,
On behalf of the organizing committee, it gives me great pleasure to extend a warm welcome to the Annual Congress on Cancer and Diagnostics, which will be held on August 23-24, 2023 in the vibrant city of Toronto, Canada.
With the theme "Building Bridges to Overcome Cancer-Free World," the Congress aims to provide a platform for researchers, clinicians, and healthcare professionals from around the world to come together, share their knowledge, and explore innovative strategies to overcome the challenges in the fight against cancer.
Our Congress will feature a comprehensive scientific program with plenary sessions, keynote speeches, and interactive workshops covering a wide range of topics in cancer research and diagnostics. Additionally, the Congress will provide ample opportunities for networking, collaboration, and knowledge exchange among the participants.
Toronto, the host city of the Congress, is a dynamic and multicultural hub of innovation and excellence in healthcare, research, and education. We are confident that the Congress will provide an enriching and unforgettable experience for all the participants.
We look forward to your active participation and contribution to the success of the Annual Congress on Cancer and Diagnostics. Thank you for your interest and support, and we hope to welcome you to Toronto in August 2023.
Sincerely,
On behalf of the Organizing Committee of the Annual Congress on Cancer and Diagnostics.
Annual Congress on Cancer and Diagnostics is set to take place on August 23-24, 2023 in the beautiful city of Toronto, Canada. The conference is expected to attract a large number of oncologists, researchers, healthcare professionals, and industry experts from around the world.
The theme of the conference is "Building Bridges to Overcome Cancer-Free World," which highlights the importance of collaboration and partnerships in the fight against cancer. The conference aims to create a platform for experts to share knowledge, research findings, and best practices in the diagnosis, treatment, and prevention of cancer.
The conference will feature a range of keynote speeches, panel discussions, and interactive sessions led by some of the leading experts in the field of oncology. Topics covered will include the latest advances in cancer research, emerging therapies, clinical trials, cancer prevention and screening, and patient care and support.
Attendees will have the opportunity to network with fellow professionals and learn about the latest technologies and innovations in the field of cancer diagnosis and treatment. The conference will also feature a poster session where researchers can present their latest findings and engage in discussions with attendees.
The Annual Congress on Cancer and Diagnostics is an excellent opportunity for professionals in the field of oncology to stay up-to-date with the latest developments in cancer research and treatment. With its focus on collaboration and partnerships, the conference promises to be a valuable platform for building new connections and advancing the fight against cancer.
Annual Congress on Cancer and Diagnostics, with its theme "Building Bridges to Overcome Cancer-Free World," holds immense importance and scope in the current global scenario. Cancer remains a major public health challenge, causing significant morbidity and mortality worldwide. With the increasing burden of cancer and the complex nature of the disease, there is a need for continued research and innovation in cancer diagnostics and treatment.
The Congress provides an opportunity for researchers, clinicians, and healthcare professionals to come together, share their expertise, and discuss new and innovative strategies to overcome the challenges posed by cancer. The Congress will feature plenary sessions, keynote speeches, and interactive workshops covering a wide range of topics related to cancer research and diagnostics, including novel therapeutic approaches, emerging technologies in cancer diagnosis, and cancer prevention and control.
Moreover, the Congress will provide a platform for networking and collaboration among researchers, clinicians, and other stakeholders in the field of cancer research and diagnostics. Participants will be able to share their experiences and best practices, learn about the latest advances in cancer research and diagnostics, and explore opportunities for collaboration and knowledge exchange.
The Congress will also showcase the latest developments in cancer research and diagnostics, including the use of artificial intelligence, precision medicine, and genomics in cancer diagnosis and treatment. This will help to advance our understanding of the underlying mechanisms of cancer and develop personalized treatment options for patients.
Finally, the Congress will be held in Toronto, a city known for its excellence in healthcare, research, and education. Participants will have the opportunity to experience the city's vibrant culture, network with experts in the field, and return to their work with renewed energy and ideas.
In summary, the Annual Congress on Cancer and Diagnostics holds great importance and scope in advancing our understanding of cancer and developing effective strategies to overcome this disease. The Congress will bring together experts from around the world to share their knowledge and explore new frontiers in cancer research and diagnostics.
Participation Options:
Cancer conference, provides the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. Mode of participation is Berlin, Germany through Power Point Presentation/ Video Presentation on Cisco Berlin, Germany.
-
Keynote speaker: 45-50 minutes
-
Speaker (oral presentation): 25-30 minutes (only one person can present)
-
Speaker (workshop): 45-50 minutes (more than 1 can present)
-
Speaker (special session): 45-50 minutes (more than 1 can present)
-
Speaker (symposium): more than 45 minutes (more than 1 can present)
-
Delegate(only registration): will have access to all the sessions with all the benefits of registration
-
Poster presenter: can present a poster and enjoy the benefits of delegate
-
Remote attendance: can participate via video presentation or e-poster presentation
-
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
-
Media partner
-
Sponsor
-
Collaborator
Participation Benefits:
-
Attend Keynote Presentation by world’s most eminent researchers
-
Access to all the sessions
-
Get Participation certificate
-
Get worldwide acknowledgment to your profile and Research
-
Get your abstracts published with unique DOI in International Journals
-
Get up to 50% discounts for publishing your entire article in our open access International Journals
-
Get Handbooks and conference kits
-
Get an access to the network with eminent personalities from worldwide
-
To learn and expand the knowledge from Top Surgeons, Professionals
-
Get your Abstract published and Certified for your participation
-
Mark new links and trigger your profession
-
Acquire a global exposure to your research idea
-
The Cancer conference cooperates with associates around the world who focused on learning concerning surgical and its specialties. This is often the best opportunity to reach the largest gathering participants. This event is recognized for distribution the data demonstrations, knowledge, information and B2B meetings with industrialists and prospective clients to form a splash with innovative products.
-
Advantage from updates and bits of knowledge on the newest surgery procedure, and in addition recommendations for guaranteeing best practice and Potentiate results.
-
Associate with 200+ amazing representatives who are included in surgery issue resolve shared difficulties and expansion from the broad familiarization of others.
-
Attend a range of informative seminars, engaging interactive presentations, and keynote panel discussions with key policy manufactures and specialists in Cancer conference
-
Be the first to showcase your research, innovation, and brand to gain competitive advantages. Meet your target audience and explore your product and services.
-
To Meet Experts
-
Learning in a New Space
-
New Tips & Tactics
-
Certification
-
Global Networking
-
Rebuild New Customer Base
-
Brand Establishment
-
Best platform for international business and Networking opportunities
-
Keynote forums by eminent Professors, Researchers
-
Novel techniques to benefit your research and innovation
-
Open Innovation Challenges
-
Meet the Editors of referred journals, Society and Association members across the world
-
Poster presentations by Young Researchers on Cancer
-
Excellent platform to showcase the latest innovations and concepts in the Neurosurgery
-
Lectures from prominent speakers
The Cancer conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:
-
Researchers
-
Scientists
-
Health care experts
-
Epidemiologists
-
Physicians
-
Nurse practitioners
-
Health care analysts
-
Business delegates
-
Young Researchers
-
Advertising and Promotion Agency Executives
-
Professionals in media sector
-
Professors
-
Surgeons
-
Fellowship Holders
-
Surgical Technicians
-
Anesthesiologists
-
Medical Students
-
Healthcare and pharmaceutical companies
The Annual Congress on Cancer and Diagnostics, with its theme "Building Bridges to Overcome Cancer-Free World," is expected to attract a large number of participants from the healthcare industry, research institutions, academia, and government organizations. The Congress will provide an opportunity for participants to learn about the latest advancements in Cancer research and diagnostics, and to network with experts in the field.
Market Size:
The global Cancer diagnostics market was valued at USD 157.6 billion in 2020 and is expected to grow at a CAGR of 7.5% from 2021 to 2028. The market growth is driven by the increasing prevalence of Cancer, the growing adoption of targeted therapies, and the emergence of novel diagnostic technologies.
Market Segmentation:
The Cancer diagnostics market is segmented by type of test, application, and region. The most common types of Cancer tests include imaging tests, biopsy, blood tests, and genetic tests. The applications of Cancer diagnostics include breast Cancer, lung Cancer, colorectal Cancer, prostate Cancer, and others.
Regional Analysis:
North America holds the largest share of the global Cancer diagnostics market, followed by Europe, Asia Pacific, and the Rest of the World. The high prevalence of Cancer in North America, coupled with the presence of leading Cancer research institutions and healthcare facilities, makes it a major market for Cancer diagnostics.
Market Trends:
The growing use of precision medicine and personalized Cancer treatments is expected to drive the growth of the Cancer diagnostics market. This trend is expected to continue as more research is conducted on the genetic and molecular mechanisms of Cancer.
In addition, the adoption of artificial intelligence and machine learning technologies is expected to revolutionize Cancer diagnostics by enabling faster and more accurate diagnosis and treatment.
Market Opportunity:
The 23rd World Congress on Cancer and Diagnostics presents a significant opportunity for participants to showcase their latest research and technologies in Cancer diagnostics. The Congress will provide a platform for participants to network with leading experts in the field, learn about the latest trends and advancements in Cancer diagnostics, and explore new business opportunities.
Conclusion:
The Annual Congress on Cancer and Diagnostics is expected to attract a large number of participants from the healthcare industry, research institutions, academia, and government organizations. The Congress provides a unique opportunity to learn about the latest advancements in Cancer research and diagnostics, and to network with experts in the field. The global Cancer diagnostics market is expected to grow significantly in the coming years, presenting a significant opportunity for participants to showcase their latest research and technologies.
